Standout Papers

VSV strains with defects in their ability to shutdown innate immunity are potent sy... 2000 2026 2008 2017 663
  1. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents (2003)
    David F. Stojdl, Brian D. Lichty et al. Cancer Cell
  2. Immunological considerations for COVID-19 vaccine strategies (2020)
    Mangalakumari Jeyanathan, Sam Afkhami et al. Nature reviews. Immunology
  3. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus (2000)
    David F. Stojdl, Brian D. Lichty et al. Nature Medicine
  4. Going viral with cancer immunotherapy (2014)
    Brian D. Lichty, Caroline J. Breitbach et al. Nature reviews. Cancer

Immediate Impact

7 by Nobel laureates 25 from Science/Nature 59 standout
Sub-graph 1 of 23

Citing Papers

Understanding and targeting resistance mechanisms in cancer
2023 Standout
Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity
2023 Standout

Works of Brian D. Lichty being referenced

Endogenous T cells prevent tumor immune escape following adoptive T cell therapy
2019
Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy
2018

Author Peers

Author Last Decade Papers Cites
Brian D. Lichty 4014 2312 2310 2859 97 7.2k
Thomas W. Dubensky 1304 4734 2711 2025 98 7.7k
Janet W. Hartley 5184 4113 4097 1759 171 11.7k
Dmitry M. Shayakhmetov 3558 1481 3306 1833 75 5.9k
Karen Mossman 1711 3796 2378 1381 152 8.4k
Jonathan L. Bramson 1748 3200 2102 2351 173 6.6k
Narendra Chirmule 3795 1998 4064 1255 114 7.6k
Raymond V. Gilden 2735 2300 2231 992 193 7.0k
Nicola La Monica 1326 1371 2323 659 103 5.5k
Dennis Panicali 1761 4519 1965 1940 83 8.3k
Michael J. Imperiale 2617 597 3420 2819 153 7.0k

All Works

Loading papers...

Rankless by CCL
2026